Josefien Hessels
Nieuwegein, UT, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Engasertib versus Placebo for Bleeding in Hereditary Hemorrhagic Telangiectasia.
Journal: The New England journal of medicine
Published: November 26, 2025
Availability, use, efficacy and safety of bevacizumab in European hereditary haemorrhagic telangiectasia centres.
Journal: British journal of clinical pharmacology
Published: June 11, 2025
Pulmonary Arteriovenous Malformation Embolization: The Role of Contrast-Enhanced CT and Standardized Outcome Measures.
Journal: Journal of vascular and interventional radiology : JVIR
Published: June 03, 2025
Family planning, sexual activity and contraception in hereditary hemorrhagic telangiectasia: a European survey study.
Journal: Orphanet journal of rare diseases
Published: September 10, 2024
Conservative Pulmonary Arteriovenous Malformation Screening in Children: Re-Evaluation of Safety.
Journal: Pediatric pulmonology
Published: May 17, 2024
Executive summary of the 14th HHT international scientific conference.
Journal: Angiogenesis
Published: July 12, 2023
Evolution of Pulmonary Arteriovenous Malformations: The Role of Contrast Echocardiography.
Journal: Chest
Published: August 03, 2022
Efficacy and Safety of Tacrolimus as Treatment for Bleeding Caused by Hereditary Hemorrhagic Telangiectasia: An Open-Label, Pilot Study.
Journal: Journal of clinical medicine
Published: August 03, 2022
Myeloid marker S100A8/A9 and lymphocyte marker, soluble interleukin 2 receptor: biomarkers of hidradenitis suppurativa disease activity?
Journal: The British journal of dermatology
Published: January 17, 2013
Showing 1-10 of 10
Last Updated: 09/26/2026